Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Inhaled Prandial Insulin Compared to Metformin Plus Glimepiride in Type 2 Diabetes

NCT00469586 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00469586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Inhaled Prandial Insulin Compared to Metformin Plus Glimepiride in Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Terminated
Start date
April 26, 2007
Completion date
April 24, 2008
Enrollment
174 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2